Menu
  • Join us
  • Login
 

Search for abstracts

You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.


ABCG2 is a physiological exporter of indoxyl sulfate, and its dysfunction accelerates the progression of chronic kidney disease.

  • At: PSWC2020 (2020)
  • Type: Poster
  • By: YAMAMOTO, Takehito (The University of Tokyo, Education Center for Medical Pharmaceutics, Department of Pharmacy, Japan)
  • Co-author(s): Takehito Yamamoto: Education Center for Medical Pharmaceutics, Department of Pharmacy, The University of Tokyo, Tokyo, Japan;Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan
    Tappei Takada: Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan
    Jeng Kae Tan: Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan
    Hiroshi Miyata: Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan
    Yoshihide Yamanashi: Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan
    Yu Toyoda: Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan
    Hiroshi Suzuki: Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan
  • Abstract:

    Background

    Uremic toxins (UTs) are accumulated in the body of chronic kidney disease (CKD) patients and leads uremic syndrome. Therefore, it is clinically important to elucidate the mechanisms underlying UTs excretion in CKD patients. Recently, we reported that ABCG2 mediates the secretion of urate in not only kidney, but also small intestine and..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 23 September 2026

FIP Congresses